Inventaire - أصدقاؤك ومجتمعاتك هم أفضل مكتبة لك - Inventaire

Antithrombotic treatment in atrial fibrillation

الكاتب

Gregory Lip

منشور في: المُهجة (مجلة)

تاريخ النشر: 2005-09-13

اللغة: الإنجليزية

الموضوع الرئيسي: رجفان أذيني

Cites articles 32

Date

العنوان

الكاتبون

2006

Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis

Gregory Lip
2005-08-01

Ximelagatran: a clinical perspective
2005-05-01

Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke
2005-02-01

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.

Hans-Christoph Diener, جوناثان إل. هالبرين
2005-01-01

Recent developments in atrial fibrillation

Gregory Lip
2005-01

Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment

Gregory Lip, Deirdre A Lane
2005-04-01

Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
2005-05-05

Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study

Simona Sacco
2004-10-01

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry

Claudia Stöllberger, Andreas Valentin
2004-09

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

جوناثان إل. هالبرين, Warren J. Manning
2004-07

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Hans-Christoph Diener, Markku Kaste, Julien Bogousslavsky
2004-03-01

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

Alistair McGuire
2004-09-01

Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi

Waldemar E. Wysokinski, Robert D McBane
2004-01-01

Idraparinux sodium: SANORG 34006, SR 34006
2003-09-01

Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice

Gregory Lip
2003-09

Combined antiplatelet therapy in atrial fibrillation: review of the literature and future avenues

Stefan H Hohnloser
2003-07-01

The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades

Bernard J Gersh, W. Michael O'Fallon
2003-07-01

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

Gregory Lip
2003-05-01

Factor X inhibitors

Gregory Lip
2003-11-01

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
2003-07-28

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

George A. Mensah
2003-12-01

High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy
2002-08-07

A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation

Gregory Lip, Andrew D Blann
2001-10-01

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Comm

Harry J. G. M. Crijns, Samuel Lévy, Adam Torbicki
2001-05-09

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
2001-02-01

Epidemiology and natural history of atrial fibrillation: clinical implications
2000-01-01

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators
1999-10-01

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis
1999-05-01

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation
1998-09-01

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

Emelia J. Benjamin
1995-11-01

Does atrial fibrillation confer a hypercoagulable state?
1995-11-01

Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation

Warren J. Manning

مقالة - wd:Q35771277

أهلًا وسهلًا إلى آنڤانتير

مكتبة أصدقائك ومجتمعاتك

تعلم المزيد

أنت غير متصل (أوفلاين)